Gao, H., Fall, T., van Dam, R. M.
, Flyvbjerg, A., Zethelius, B., Ingelsson, E. & Hägg, S. (2013).
Evidence of a Causal Relationship Between Adiponectin Levels and Insulin Sensitivity: A Mendelian Randomization Study.
Diabetes,
62(4), 1338-44.
https://doi.org/10.2337/db12-0935Gordin, D., Soro-Paavonen, A., Thomas, M. C., Harjutsalo, V., Saraheimo, M.
, Bjerre, M., Forsblom, C.
, Flyvbjerg, A., Groop, P.-H. & FinnDiane Study Group (2013).
Osteoprotegerin is an independent predictor of vascular events in finnish adults with type 1 diabetes.
Diabetes Care,
36(7), 1827-33.
https://doi.org/10.2337/dc12-2170Grosse, J., Warnke, E., Pohl, F.
, Magnusson, N. E., Wehland, M., Infanger, M., Eilles, C.
& Grimm, D. G. (2013).
Impact of Sunitinib on Human Thyroid Cancer Cells.
Cellular Physiology and Biochemistry,
32(1), 154-170.
https://doi.org/10.1159/000350132Grosse, J., Warnke, E., Wehland, M., Pietsch, J., Pohl, F., Wise, P.
, Magnusson, N. E., Eilles, C.
& Grimm, D. G. (2013).
Mechanisms of apoptosis in irradiated and sunitinib-treated follicular thyroid cancer cells.
Apoptosis.
https://doi.org/10.1007/s10495-013-0937-0Groth, K. A., Skakkebæk, A., Høst, C., Gravholt, C. H. & Bojesen, A. (2013).
Klinefelter syndrome--a clinical update.
Journal of Clinical Endocrinology and Metabolism,
98(1), 20-30.
https://doi.org/10.1210/jc.2012-2382
Gu, H. F., Gu, T., Hilding, A., Zhu, Y., Kärvestedt, L., Ostenson, C.-G., Lai, M., Kutsukake, M.
, Frystyk, J., Tamura, K. & Brismar, K. (2013).
Evaluation of IGFBP-7 DNA methylation changes and serum protein variation in Swedish subjects with and without type 2 diabetes.
Clinical Epigenetics,
5(1), 20.
https://doi.org/10.1186/1868-7083-5-20Hangaard, J., Andersen, M.
, Laursen, T., Nielsen, E. H., Storm, T. L.
, Rasmussen, Å. K., Poulsen, P. L., Friberg, A.
, Ladekarl, M., Schaffalitzky de Muckadell, O. B., Wilson, B.
, Knigge, U. P. & Grønbæk, H. (2013).
Baggrundsnotat for brug af langtidsvirkende somatostatinanaloger og GH-receptorantagonist til akromegali. In
Baggrundsnotat for brug af langtidsvirkende somatostatinanaloger og GH-receptorantagonist til akromegali. http://www.regioner.dk/~/media/Mediebibliotek_2011/SUNDHED/Medicin/Rådet%20for%20Anvendelse%20af%20Dyr%20Sygehusmedicin/20121221%20Baggrundsnotat_akromegali%20godkendt%20af%20RADS.ashx